|
ZKSCAN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.95579996431894E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.61780000010425E-07 |
| Normal-vs-Stage2 |
4.609700E-04 |
| Normal-vs-Stage3 |
2.85349999185058E-09 |
| Normal-vs-Stage4 |
3.52100000000632E-06 |
| Stage1-vs-Stage2 |
9.228400E-01 |
| Stage1-vs-Stage3 |
1.104620E-01 |
| Stage1-vs-Stage4 |
3.825400E-01 |
| Stage2-vs-Stage3 |
3.112400E-01 |
| Stage2-vs-Stage4 |
4.685400E-01 |
| Stage3-vs-Stage4 |
8.272600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79850000447956E-08 |
| Normal-vs-AfricanAmerican |
2.022100E-02 |
| Normal-vs-Asian |
2.11499999999143E-05 |
| Caucasian-vs-AfricanAmerican |
2.941400E-01 |
| Caucasian-vs-Asian |
7.453800E-01 |
| AfricanAmerican-vs-Asian |
2.796400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13260001377569E-09 |
| Normal-vs-Female |
1.4581999996377E-07 |
| Male-vs-Female |
1.393180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.88250000002321E-06 |
| Normal-vs-Age(41-60Yrs) |
4.79459999480625E-08 |
| Normal-vs-Age(61-80Yrs) |
1.97280000002742E-07 |
| Normal-vs-Age(81-100Yrs) |
3.164800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.322800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.067800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.814200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.998200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.938400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.457400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.501200E-03 |
| Classical-VS-Follicular |
1.010020E-02 |
| Classical-VS-Other |
1.134000E-01 |
| Classical-VS-Normal |
2.966499999979E-06 |
| Tall-VS-Follicular |
5.294800E-01 |
| Tall-VS-Other |
6.043600E-01 |
| Tall-VS-Normal |
7.20939999920844E-08 |
| Follicular-VS-Other |
4.340600E-01 |
| Follicular-VS-Normal |
1.14629999936611E-08 |
| Other-VS-Normal |
1.883560E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.37289999766222E-08 |
| Normal-vs-N1 |
3.73280000000031E-05 |
| N0-vs-N1 |
9.242600E-01 |
|
|
